Importantly, we reveal that LXN deficiency in mice improves obesity-associated liver steatosis, glucose tolerance and insulin resistance, indicating the potential benefits of LXN deficiency in the diet-induced pathogenesis of obesity and obesity-associated metabolic syndrome (Fig S2). The gene discussed is LXN; the disease is metabolic syndrome.